VAPB and amyotrophic lateral sclerosis: Interestingly, accumulation of fused in sarcoma (FUS), a key pathological feature characterizing ALS, also interrupts VAPB and PTPIP51 association and MAM tethering via GSK-3β activation (Stoica et al., 2016).